Condition
Testicular Cancer clinical trials and research
Research outlook What's coming for Testicular cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 28 Testicular Cancer clinical trials that are recruiting, at sites in 11 countries (most in United States (14), Italy (3), Netherlands (3)). By phase: Phase 1 (3), Phase 2 (3), Phase 1/2 (2), Phase 3 (1). The most active sponsors are IRCCS Azienda Ospedaliero-Universitaria di Bologna (2), University of Arizona (2), Indiana University (2). There are also 7 NIH-funded research projects on Testicular Cancer, with $2.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 28Clinical trials
- 7NIH research projects
- 11Countries
Newest Testicular Cancer clinical trials
All recruiting trials (28)
-
Primary retroperitoneal lymph node surgery versus chemotherapy for good‑prognosis metastatic testicular cancer
This study will test whether primary RPLND (surgery) instead of standard chemotherapy leads to fewer side effects and better quality of life for men 18 and older with good‑prognosis metastatic testicular cancer.
-
Sodium thiosulfate to protect hearing during cisplatin therapy in adults with solid tumors
This study tests Pedmark sodium thiosulfate to see if it reduces hearing loss in adults receiving standard cisplatin chemotherapy.
-
Navigation program for young cancer survivors
This project tests an adapted navigation program to help adolescent and young adult cancer survivors get timely care within Kaiser Permanente Southern California.
-
Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors
This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.
-
Testing GV20-0251 for advanced or treatment‑resistant solid tumors
This study will test whether GV20-0251 is safe and tolerable when given every three weeks to adults with advanced or treatment‑resistant solid tumors such as liver, lung, pancreatic cancer, and melanoma.
-
How retroperitoneal lymph node dissection affects urination and sexual function
This project will see if retroperitoneal lymph node dissection (RPLND) for testicular cancer changes urination, ejaculation, erections, and quality of life in adult men.
-
Primary retroperitoneal lymph node dissection for seminoma with limited retroperitoneal lymph node spread
This trial will try surgery (retroperitoneal lymph node dissection) to treat men with pure seminoma who have one or two small (≤3 cm) retroperitoneal lymph node metastases and normal tumor markers.
-
Low-dose aspirin to prevent venous blood clots during chemotherapy for advanced germ cell (testicular) cancer
This trial will see if taking one daily low-dose aspirin (81 mg) during cisplatin chemotherapy prevents venous blood clots over six months in adults up to age 70 with high-risk advanced germ cell or testicular cancer.
-
Comparing two surgical techniques for testicular cancer treatment
This study is testing if a new surgical method for treating testicular cancer can help patients feel less pain and need fewer pain medications after surgery compared to the standard method.
-
Radiation plus tarlatamab for DLL3-expressing tumors
This trial will test whether giving tarlatamab together with standard palliative or consolidative radiation is safe for adults with DLL3-expressing or DLL3-prevalent tumors such as melanoma, medullary thyroid cancer, sinonasal undifferentiated carcinoma, esthesioneuroblastoma, and bladder cancer.
-
Evaluating surgical outcomes for testicular cancer treatment
This study is testing different surgical methods for treating testicular cancer to see how well they work and how they affect patients' lives.
-
Treatment of rare advanced tumors with a combination of drugs
This study is testing a new combination of drugs to see if it can help people with rare advanced tumors live longer and feel better.
-
Using brodalumab to treat immune-related side effects from cancer therapy
This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.
-
Evaluating microRNAs for diagnosing testicular cancer in small masses.
This study is testing if certain tiny molecules in the blood can help doctors diagnose testicular cancer in adults who have small testicular masses.
-
Comparing intrathecal morphine and intravenous methadone for pain relief after surgery for testicular cancer
This study is testing whether pain relief after testicular cancer surgery is better with intrathecal morphine or intravenous methadone to help patients feel more comfortable and use less medication.
-
Evaluating CTIM-76 for patients with recurring ovarian and other advanced cancers
This study is testing a new treatment called CTIM-76 to see if it can help people with hard-to-treat ovarian and other advanced cancers feel better and live longer.
-
Understanding the quality of life and outcomes for testicular cancer patients
This study is trying to understand how testicular cancer affects patients' quality of life and well-being over time to help improve their care and treatment.
-
Helping adolescent and young adult cancer survivors manage symptoms and stay engaged in post-treatment care
This trial will test whether AYA STEPS, a six-session digital program, can help adolescent and young adult cancer survivors reduce symptoms and keep up with recommended follow-up care.
-
Digital peer support for young adults with cancer
This study is testing a digital support program to see if it can help young adults who have finished cancer treatment by connecting them with trained peers for guidance and encouragement.
-
Investigating cognitive impairment in young cancer patients during and after chemotherapy
This study is testing how chemotherapy affects memory and attention in children and young adults with cancer to better understand their cognitive challenges during and after treatment.
-
Biobehavioral intervention for young adult testicular cancer survivors
This study is testing a new therapy to help young adult testicular cancer survivors manage their emotions and stress better, comparing it to regular supportive listening over eight weeks.
-
Home-based follow-up for testicular cancer patients
This study tests if a home-based follow-up for people who have recently finished treatment for testicular cancer can help them feel better and less anxious compared to regular hospital visits.
-
Investigating heart disease in testicular cancer survivors
This study is testing if testicular cancer survivors who had certain treatments are at higher risk for heart disease, using blood tests and imaging to find early signs of problems.
-
Observational analysis of silicone gel-filled testicular implants
This study is trying to see how well silicone gel-filled testicular implants work and how satisfied patients are after getting them, for people who need these implants due to various medical conditions.
-
Investigating early ageing in young cancer patients during treatment
This study is trying to see how cancer treatment affects early aging and heart health in young adults aged 18-39 who are undergoing therapy for cancer.
-
Impact of chemotherapy on early ageing in testicular cancer patients
This study tests how chemotherapy for testicular cancer affects aging in patients by looking at changes in their skin and fat cells.
-
AI-based precision oncology clinical trial matching and registry
This study is testing whether an AI tool can help match cancer patients with the right clinical trials based on their specific cancer details to see if it improves their chances of getting into trials and their overall outcomes.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Biobehavioral support to improve life after testicular cancer in young adults
A youth-focused program helps young men who have survived testicular cancer manage emotions, goals, and health changes after treatment to reduce distress and long-term problems.
-
Support to reduce long-term emotional, thinking, and work problems after testicular cancer for young adults
This project looks at how a therapy called Goal-focused Emotion-Regulation Therapy (GET) and stress-related biology relate to mental health, thinking, and work life in young adults who are long-term survivors of testicular cancer.
-
Recreating early testicular cancer precursors in the lab
They will grow patient-derived germ cells in lab models to recreate the early precursors of adult testicular cancer for young men at risk.
-
Helping Young Adults with Testicular Cancer Thrive After Treatment
This project offers support to young adults who have completed testicular cancer treatment, helping them manage lasting challenges and achieve their life goals.
-
Investigating how cannabinoids may increase the risk of testicular cancer.
This study is looking into how exposure to cannabis during pregnancy might affect the development of testicular cancer in boys, using lab models to see how substances like THC and CBD could impact the growth of important cells in the testicles.
-
Creating lab models of testicular cancer precursors using stem cells.
This study is exploring how testicular cancer starts by creating lab models using special cells from patients, which will help researchers learn more about the disease and find better ways to treat it.
-
Helping young adult testicular cancer survivors manage their health and emotions
This study is testing a supportive program designed to help young adult testicular cancer survivors feel better both physically and emotionally as they adjust back to everyday life after treatment.
Related topics
Quick answers
How many Testicular Cancer clinical trials are recruiting right now?
28, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (14 trials), Italy (3 trials), Netherlands (3 trials), China (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 3, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.